论文部分内容阅读
The quest for neuroprotective drugs to slow the progression of neurodegenerative diseases(NDDs),including Alzheimer's disease(AD),Parkinson's disease(PD),and Huntington's disease(HD),has been largely unrewarding.Preclinical evidence suggests t